Canopy Growth Posts Q1 Revenue and Margin Gains on Cannabis Expansion
TipRanks (Fri, 7-Aug 8:20 AM ET)
Canopy Growth gains as all-around performance drives Q1 growth
Seeking Alpha News (Fri, 7-Aug 7:42 AM ET)
Seeking Alpha News (Fri, 7-Aug 7:15 AM ET)
Earnings Snapshot: Canopy Growth sees H2 FY2027 boost as Q1 adjusted gross margin reaches 31%
Seeking Alpha News (Fri, 7-Aug 7:08 AM ET)
Options Volatility and Implied Earnings Moves Today, August 07, 2026
TipRanks (Fri, 7-Aug 7:05 AM ET)
Canopy Growth GAAP EPS of -$0.03 in-line, revenue of $100.36M beats by $17.68M
Seeking Alpha News (Fri, 7-Aug 7:02 AM ET)
Business Wire (Fri, 7-Aug 7:00 AM ET)
These Are the Stocks Reporting Earnings Today – August 7, 2026
TipRanks (Fri, 7-Aug 4:00 AM ET)
Here are the major earnings before the open Friday
Seeking Alpha News (Thu, 6-Aug 6:00 PM ET)
Canopy Growth Q1 preview: Another loss-making quarter before EBITDA turnaround
Seeking Alpha News (Thu, 6-Aug 11:35 AM ET)
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
Canopy Growth - Common Shares trades on the NASDAQ stock market under the symbol CGC.
As of August 7, 2026, CGC stock price climbed to $0.99 with 3,012,399 million shares trading.
CGC has a beta of 1.02, meaning it tends to be more sensitive to market movements. CGC has a correlation of 0.03 to the broad based SPY ETF.
CGC has a market cap of $417.93 million. This is considered a Small Cap stock.
Last quarter Canopy Growth - Common Shares reported $52 million in Revenue and -$.29 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.23.
In the last 3 years, CGC traded as high as $19.20 and as low as $.77.
The top ETF exchange traded funds that CGC belongs to (by Net Assets): MJ, YOLO.
CGC has underperformed the market in the last year with a return of -5.7%, while the SPY ETF gained +23.5%. In the last 3 month period, CGC fell short of the market, returning -13.9%, while SPY returned +5.7%. However, in the most recent 2 weeks CGC has outperformed the stock market by returning +9.4%, while SPY returned +4.8%.
CGC support price is $.91 and resistance is $.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CGC shares will trade within this expected range on the day.